Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy evaluation of artemisinin combination therapy in Kenya
PACTR202404710340979Phase 4Not yet recruiting
- Sponsor
- Kenya Medical Research Institute
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of artemether + lumefantrine and dihydroartemisinin + piperaquine in malaria and Malaria, sponsored by Kenya Medical Research Institute. Planned start May 2024; status: not yet recruiting.
02
Drugs
artemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR202404710340979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202404710340979.